| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.05 | 0.7 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.16 | 0.7 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.022 | 0.7 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.05 | 0.7 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.058 | 0.7 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |